Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

GRIPP2 checklists guide PPI evidence reporting

GRIPP2 checklists guide PPI evidence reporting PharmacoEconomics & Outcomes News 784, p18 - 12 Aug 2017 GRIPP2 checklists guide PPI evidence reporting Guidance for Reporting Involvement of Patients and the Public-long form (GRIPP2-LF) and -short form (GRIPP2-SF) checklists have been developed to improve the patient and public involvement (PPI) evidence base, say UK-based authors of a study published in Research Involvement and Engagement. Researchers aimed to develop international consensus on the key items to report to enhance the quality, transparency, and consistency of the PPI evidence base, and involved patients in the development of GRIPP2. Using the EQUATOR method for developing guidelines for outcomes reporting, the original GRIPP checklist was revised based on evidence from an updated systematic review. Responses from a Delphi survey were used to develop consensus on outcomes to be included in GRIPP2. Participants of the Delphi survey included researchers, funders, patients, carers, editors, and individuals from international research agencies from countries including Australia, Canada, Europe and the US. In total, 143 participants participated in round one of the Delphi survey, and 83% and 78% of these participants, respectively, took part in rounds two and three. Based on responses, two GRIPP2 versions were developed. The 32-item GRIPP2-LF version, developed for studies with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

GRIPP2 checklists guide PPI evidence reporting

PharmacoEconomics & Outcomes News , Volume 784 (1) – Aug 12, 2017
Download PDF
1 page

GRIPP2 checklists guide PPI evidence reporting

Abstract

PharmacoEconomics & Outcomes News 784, p18 - 12 Aug 2017 GRIPP2 checklists guide PPI evidence reporting Guidance for Reporting Involvement of Patients and the Public-long form (GRIPP2-LF) and -short form (GRIPP2-SF) checklists have been developed to improve the patient and public involvement (PPI) evidence base, say UK-based authors of a study published in Research Involvement and Engagement. Researchers aimed to develop international consensus on the key items to report to enhance the...
Loading next page...
1
 
/lp/springer_journal/gripp2-checklists-guide-ppi-evidence-reporting-VcKJLpfbCB

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
ISSN
1173-5503
eISSN
1179-2043
DOI
10.1007/s40274-017-4229-8
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics & Outcomes News 784, p18 - 12 Aug 2017 GRIPP2 checklists guide PPI evidence reporting Guidance for Reporting Involvement of Patients and the Public-long form (GRIPP2-LF) and -short form (GRIPP2-SF) checklists have been developed to improve the patient and public involvement (PPI) evidence base, say UK-based authors of a study published in Research Involvement and Engagement. Researchers aimed to develop international consensus on the key items to report to enhance the quality, transparency, and consistency of the PPI evidence base, and involved patients in the development of GRIPP2. Using the EQUATOR method for developing guidelines for outcomes reporting, the original GRIPP checklist was revised based on evidence from an updated systematic review. Responses from a Delphi survey were used to develop consensus on outcomes to be included in GRIPP2. Participants of the Delphi survey included researchers, funders, patients, carers, editors, and individuals from international research agencies from countries including Australia, Canada, Europe and the US. In total, 143 participants participated in round one of the Delphi survey, and 83% and 78% of these participants, respectively, took part in rounds two and three. Based on responses, two GRIPP2 versions were developed. The 32-item GRIPP2-LF version, developed for studies with

Journal

PharmacoEconomics & Outcomes News – Springer Journals

Published: Aug 12, 2017

There are no references for this article.